Literature DB >> 2956523

A functional response to D1 dopamine receptor stimulation in the central nervous system: inhibition of the release of [3H]-serotonin from the rat substantia nigra.

S Benkirane, S Arbilla, S Z Langer.   

Abstract

The influence of dopamine receptor agonists on the calcium dependent electrically-evoked release of [3H]-serotonin was studied in the superfused rat substantia nigra. The electrically-evoked overflow of [3H]-serotonin was significantly inhibited by micromolar concentrations of exogenous dopamine and of the D1-selective dopamine receptor agonists, fenoldopam and SKF 38393. The inhibitory effects of dopamine and fenoldopam on [3H]-serotonin release were antagonized by the D1-selective dopamine receptor antagonist SCH 23390. S-sulpiride, an antagonist of D2 receptors failed to antagonize the inhibitory effects of dopamine on [3H]-serotonin release. Moreover, quinperol, the selective D2 receptor agonist did not modify the electrically evoked release of [3H]-serotonin. In the presence of nomifensine, SCH 23390 but not S-sulpiride enhanced in a concentration dependent manner the electrically-evoked release of [3H]-serotonin. Under similar experimental conditions, exposure to fenoldopam did not inhibit the electrically-evoked release of [3H]-serotonin from rat hippocampal or hypothalamic slices. These results indicate that, in rat substantia nigra, exogenous as well as endogenous dopamine causes inhibition of serotonin release by activation of dopamine receptors of the D1-subtype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956523     DOI: 10.1007/bf00169115

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  50 in total

1.  Origin and distribution of glutamate decarboxylase in substantia nigra of the cat.

Authors:  F Fonnum; I Grofová; E Rinvik; J Storm-Mathisen; F Walberg
Journal:  Brain Res       Date:  1974-05-10       Impact factor: 3.252

2.  5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.

Authors:  P E Hicks; H Schoemaker; S Z Langer
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

3.  Release of dopamine in vivo from cat substantia nigra.

Authors:  A Nieoullon; A Cheramy; J Glowinski
Journal:  Nature       Date:  1977-03-24       Impact factor: 49.962

4.  Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain.

Authors:  I Kanazawa; P C Emson; A C Cuello
Journal:  Brain Res       Date:  1977-01-07       Impact factor: 3.252

5.  D-1 dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390.

Authors:  T M Dawson; D R Gehlert; H I Yamamura; A Barnett; J K Wamsley
Journal:  Eur J Pharmacol       Date:  1985-02-05       Impact factor: 4.432

Review 6.  Two dopamine receptors: biochemistry, physiology and pharmacology.

Authors:  J C Stoof; J W Kebabian
Journal:  Life Sci       Date:  1984-12-03       Impact factor: 5.037

7.  Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.

Authors:  S Z Langer; C Moret
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

8.  Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.

Authors:  R A Hahn; J R Wardell; H M Sarau; P T Ridley
Journal:  J Pharmacol Exp Ther       Date:  1982-11       Impact factor: 4.030

9.  Stereoselectivity of presynaptic autoreceptors modulating dopamine release.

Authors:  S Arbilla; S Z Langer
Journal:  Eur J Pharmacol       Date:  1981-12-17       Impact factor: 4.432

10.  Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.

Authors:  S Arbilla; L A Kamal; S Z Langer
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

View more
  4 in total

1.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission.

Authors:  R T Fremeau; G E Duncan; M G Fornaretto; A Dearry; J A Gingrich; G R Breese; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

2.  Differential effects of acute administration of SCH-23390, a D₁ receptor antagonist, and of ethanol on swimming activity, anxiety-related responses, and neurochemistry of zebrafish.

Authors:  Steven Tran; Magda Nowicki; Arrujyan Muraleetharan; Diptendu Chatterjee; Robert Gerlai
Journal:  Psychopharmacology (Berl)       Date:  2015-07-26       Impact factor: 4.530

Review 3.  Clinical investigation of monoamine neurotransmitter interactions.

Authors:  J K Hsiao; W Z Potter; H Agren; R R Owen; D Pickar
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.

Authors:  M Matsumoto; M Yoshioka; H Togashi; T Ikeda; H Saito
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.